BT
Better Therapeutics, Inc.
BTTX · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $5.45K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
-
N/A P/FCF N/A
P/E N/A
EV/FFO N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor Asset turnover 0.00x
ROIC 273.72%
ROA 173.30%
Debt
64 /100
Moderate Net debt/EBITDA 0.02x
Current ratio 1.37x
Int. coverage -25.66x
Stability
1 /100
Unstable Profitable years 0
Beta 0.19x
EPS volatility 167.43%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre BTTX
Online
Sector
Healthcare
Industry
Medical - Specialties
CEO
Craig R. Jalbert
Employees
54
Headquarters
San Francisco
Evenimente viitoare
12 NOV.
Earnings
Upcoming earnings report